Farallon Capital Partners, L.P.

13F Holdings History for Beam Therapeutics Inc. - Common Stock (BEAM)

Symbol: BEAM on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 9.97M shares
Security Ownership: 9.99%

Dapice Joshua J. ownership in Beam Therapeutics Inc. Common Stock (BEAM)

2025-05-13 - Dapice Joshua J. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.97M shares of Beam Therapeutics Inc. Common Stock (BEAM). This represents 9.99% percent ownership of the company. In their previous filing dated 2025-02-05, Farallon Capital Partners, L.P. had reported owning 8.24M shares, indicating an increase of 21% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Dapice Joshua J.	9.99%	+0.9%	$154M	9.97M	+1,733,857	+21%	$15.47	13G/A	3/31/2025	13 May 2025 15:45:40
Dapice Joshua J.	9.9%		$127M	8.24M			$15.47	13G/A	12/31/2024	5 Feb 2025 19:30:58